Featured Research

from universities, journals, and other organizations

New Herpes Treatment From Common Herb

Date:
May 20, 2003
Source:
American Society For Microbiology
Summary:
A new anti-herpes agent derived from a common herb effectively treats and prevents the disease in animals. Researchers from Dalhousie University in Nova Scotia present their data today at the 103rd General Meeting of the American Society for Microbiology.

WASHINGTON, DC – May 19, 2003 – A new anti-herpes agent derived from a common herb effectively treats and prevents the disease in animals. Researchers from Dalhousie University in Nova Scotia present their data today at the 103rd General Meeting of the American Society for Microbiology.

"Prunella vulgaris [also known as self-heal] is a perennial plant commonly found in China, the British Isles, Europe, and North America. In herbal literature, P. vulgaris has been described as a hot water infusion to treat sores in the mouth and throat, as an astringent for internal and external purposes, as a crude anti-cancer drug, and as a herbal remedy to lower high blood pressure," says Song Lee, one of the researchers on the study.

Lee and his colleagues extracted a lignin-carbohydrate compound from the plant, which was incorporated into a topical cream and tested on mice and guinea pigs with experimental herpes simplex virus-1 (HSV-1) and herpes simplex virus-2 (HSV-2) infections. Guinea pigs receiving the lignin-carbohydrate complex cream treatment showed a significant reduction in skin lesions compared to those that received no treatment. Mice receiving the lignin-carbohydrate complex cream treatment showed a significant increase in survival rate compared to animals that received no treatment.

"The anti-HSV compound from P. vulgaris is a novel lignin-carbohydrate complex with potent activity against HSV-1 and HSV-2 and has a different anti-herpes mechanism than acyclovir, the current clinical anti-herpes drug," says Lee. "Given the high incidence of herpes infection and the emergence of acyclovir-resistant strains of herpes viruses, the Prunella lignin-carbohydrate complex may prove to be a useful new anti-herpes drug."


Story Source:

The above story is based on materials provided by American Society For Microbiology. Note: Materials may be edited for content and length.


Cite This Page:

American Society For Microbiology. "New Herpes Treatment From Common Herb." ScienceDaily. ScienceDaily, 20 May 2003. <www.sciencedaily.com/releases/2003/05/030520083354.htm>.
American Society For Microbiology. (2003, May 20). New Herpes Treatment From Common Herb. ScienceDaily. Retrieved October 1, 2014 from www.sciencedaily.com/releases/2003/05/030520083354.htm
American Society For Microbiology. "New Herpes Treatment From Common Herb." ScienceDaily. www.sciencedaily.com/releases/2003/05/030520083354.htm (accessed October 1, 2014).

Share This



More Health & Medicine News

Wednesday, October 1, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Some Positive Ebola News: Outbreak 'Contained' In Nigeria

Some Positive Ebola News: Outbreak 'Contained' In Nigeria

Newsy (Sep. 30, 2014) The CDC says a new case of Ebola has not been reported in Nigeria for more than 21 days, leading to hopes the outbreak might be nearing its end. Video provided by Newsy
Powered by NewsLook.com
UN Ebola Mission Head: Immediate Action Is Crucial

UN Ebola Mission Head: Immediate Action Is Crucial

AFP (Sep. 30, 2014) The newly appointed head of the United Nations Mission for Ebola Emergency Response (UNMEER), Anthony Banbury, outlines operations to tackle the virus. Duration: 00:39 Video provided by AFP
Powered by NewsLook.com
CDC Confirms First Case of Ebola in US

CDC Confirms First Case of Ebola in US

AP (Sep. 30, 2014) The CDC has confirmed the first diagnosed case of Ebola in the United States. The patient is being treated at a Dallas hospital after traveling earlier this month from Liberia. (Sept. 30) Video provided by AP
Powered by NewsLook.com
New Breast Cancer Drug Extends Lives In Clinical Trial

New Breast Cancer Drug Extends Lives In Clinical Trial

Newsy (Sep. 30, 2014) In a clinical trial, breast cancer patients lived an average of 15 months longer when they received new drug Perjeta along with Herceptin. Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:

Strange & Offbeat Stories


Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins